ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 135 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,541 | -35.2% | 18,765 | -1.9% | 0.00% | – |
| Q2 2023 | $198,410 | +44.8% | 19,133 | +13.0% | 0.00% | – |
| Q1 2023 | $136,988 | -52.2% | 16,933 | -7.0% | 0.00% | – |
| Q4 2022 | $286,776 | +10.7% | 18,208 | +11.0% | 0.00% | – |
| Q3 2022 | $259,000 | +14.6% | 16,397 | +1.5% | 0.00% | – |
| Q2 2022 | $226,000 | -59.4% | 16,157 | -49.9% | 0.00% | – |
| Q1 2022 | $556,000 | -15.8% | 32,253 | -29.0% | 0.00% | – |
| Q4 2021 | $660,000 | -30.8% | 45,405 | -14.3% | 0.00% | -100.0% |
| Q3 2021 | $954,000 | +22.9% | 52,995 | +19.9% | 0.00% | 0.0% |
| Q2 2021 | $776,000 | – | 44,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |